Inogen EVP sells 10,770 shares under 10b5-1 plan

Inogen Inc executive Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief Human Resources Officer, reported an open-market sale of 10,770 shares of common stock on May 29, 2026.

Rhea-AI Filing Summary

Inogen Inc executive Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief Human Resources Officer, reported an open-market sale of 10,770 shares of common stock on May 29, 2026. The shares were sold at a weighted average price of $6.5286, within a price range of $6.41 to $6.62.

The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026. Following this sale, she directly holds 15,977 shares of Inogen common stock.

Insider Trade Summary 10b5-1

Net Seller: 10,770 shares

Net Sell 1 txn

Insider Yi Boyer Jennifer M

Role EVP Entrprs Enblmnt, Ch HR Off

Sold 10,770 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,770	$6.5286	$70K

Holdings After Transaction: Common Stock — 15,977 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.
2. F2. Represents the weighted average share price of an aggregate total of 10,770 shares sold in the price range of $6.41 to $6.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 10,770 shares Average sale price: $6.5286 per share Post-transaction holdings: 15,977 shares +1 more

4 metrics

Shares sold 10,770 shares Open-market sale on May 29, 2026

Average sale price $6.5286 per share Weighted average for 10,770 shares

Post-transaction holdings 15,977 shares Total common stock directly held after sale

Sale price range $6.41 to $6.62 per share Range for reported sales aggregated in Form 4

Key Terms

Rule 10b5-1 trading plan, weighted average share price, open-market sale, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average share price financial

"Represents the weighted average share price of an aggregate total of 10,770 shares sold"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inogen (INGN) report for Jennifer M. Yi Boyer?

Inogen reported that executive Jennifer M. Yi Boyer sold 10,770 shares of common stock. The trade was an open-market sale executed on May 29, 2026, as disclosed in a Form 4 insider filing.

At what price did Jennifer M. Yi Boyer sell Inogen (INGN) shares?

She sold 10,770 Inogen shares at a weighted average price of $6.5286. According to the filing, the sales occurred within a price range between $6.41 and $6.62 per share.

Was the Inogen (INGN) insider sale by Jennifer M. Yi Boyer under a 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan. This plan was adopted by Jennifer M. Yi Boyer on February 27, 2026, before the reported transaction date.

How many Inogen (INGN) shares does Jennifer M. Yi Boyer hold after the sale?

After selling 10,770 shares, she directly holds 15,977 Inogen common shares. This post-transaction ownership figure is explicitly reported as the total shares following the transaction in the Form 4.

What role does Jennifer M. Yi Boyer hold at Inogen (INGN)?

Jennifer M. Yi Boyer serves as Executive Vice President of Enterprise Enablement and Chief Human Resources Officer. Her officer status and title are disclosed in the Form 4 insider ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yi Boyer Jennifer M

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MASSACHUSETTS 01915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Entrprs Enblmnt, Ch HR Off

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/29/2026		S(1)		10,770	D	$6.5286(2)	15,977	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.

2. Represents the weighted average share price of an aggregate total of 10,770 shares sold in the price range of $6.41 to $6.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Mary Wright, as Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)